China CAS:175865-59-5 Manufacturer

In 2024, CPhI China will continue to be a unique opportunity for global pharmaceutical companies, manufacturers and suppliers. We will be waiting for you at the W1G20 booth on time to explore and interpret new trends in the pharmaceutical industry and interact with each other to further expand their business cooperation and various business opportunities. See you in Shanghai!

The API -- cyproterone acetate, successfully passed the EU-GMP audit in April 2024.

CPhI South East Asia 2025 will be held at MITEC, Kuala Lumpur, Malaysia from 16 Jul to 18 Jul 2025, our booth number is N33.

Finasteride is one of the most widely researched and prescribed medications for treating male pattern hair loss and benign prostatic hyperplasia (BPH). By targeting the hormonal pathways responsible for hair follicle miniaturization and prostate enlargement, Finasteride has become a cornerstone pharmaceutical ingredient in dermatology and urology. This in-depth guide explores how Finasteride works, its benefits, dosage, safety profile, side effects, comparisons with alternatives, and why global pharmaceutical manufacturers such as Humanwell play a crucial role in its production and supply.

As a trusted pharmaceutical manufacturer, Humanwell has continuously focused on providing high-quality active pharmaceutical ingredients and healthcare solutions. Among these, Dutasteride has gained significant attention worldwide due to its proven effectiveness in treating benign prostatic hyperplasia (BPH) and its growing application in hair loss management. As more healthcare professionals and consumers seek reliable solutions, understanding how Dutasteride works, its benefits, safety profile, and potential applications becomes increasingly important.